Ulrich Baxa and Natalia De Val Alda look at the Titan Krios microscope at the Frederick National Laboratory.

FREDERICK, Md. -- Nearly one-third of all human cancers are driven by mutations in RAS genes, including almost all pancreatic cancers. Treating these cancers has puzzled scientists for decades, and many RAS proteins are considered virtually undruggable.